Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 08, 2021

SELL
$99.61 - $142.12 $112,360 - $160,311
-1,128 Closed
0 $0
Q3 2020

Oct 13, 2020

SELL
$72.92 - $102.01 $8,531 - $11,935
-117 Reduced 9.4%
1,128 $114,000
Q1 2020

May 12, 2020

BUY
$37.9 - $104.44 $13,340 - $36,762
352 Added 39.42%
1,245 $72,000
Q4 2019

Feb 14, 2020

SELL
$77.66 - $99.74 $11,416 - $14,661
-147 Reduced 14.13%
893 $83,000
Q3 2019

Oct 22, 2019

BUY
$90.37 - $122.49 $83,411 - $113,058
923 Added 788.89%
1,040 $93,000
Q2 2019

Jul 22, 2019

BUY
$89.51 - $118.04 $1,521 - $2,006
17 Added 17.0%
117 $13,000
Q2 2018

Aug 14, 2018

BUY
$37.84 - $69.96 $3,784 - $6,995
100 New
100 $5,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.91B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Flagship Harbor Advisors, LLC Portfolio

Follow Flagship Harbor Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.